Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R35-HL135824)
Received: 21 January 2020
Accepted: 17 September 2020
First Online: 18 December 2020
: G.R.A. works for Regeneron Pharmaceuticals. P.N. reports grant support from Amgen, Apple, and Boston Scientific, and is a scientific advisor to Apple. S.A.L. receives sponsored research support from Bristol Myers Squibb / Pfizer, Bayer HealthCare, and Boehringer Ingelheim, and has consulted for Bristol Myers Squibb / Pfizer. P.T.E. has consulted for Novartis, Quest Diagnostics and Bayer AG. S.T.W. has received royalties from UpToDate. S.A. holds equity in 23andMe, Inc. All other authors declare no competing interests. The spouse of C.J.W. works for Regeneron Pharmaceuticals.